tiprankstipranks
Trending News
More News >
IntelliPharmaCeutics International (IPCIQ)
OTHER OTC:IPCIQ
US Market

IntelliPharmaCeutics International (IPCIQ) Financial Statements

Compare
145 Followers

IntelliPharmaCeutics International Financial Overview

IntelliPharmaCeutics International's market cap is currently $2.43M. The company's EPS TTM is $; its P/E ratio is ―; IntelliPharmaCeutics International is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 22Nov 21Nov 20Nov 19Nov 18
Income Statement
Total Revenue
Gross Profit$ 65.73K-$ 1.40M$ 3.45M$ 1.59M
Operating Income$ -2.85M$ -4.17M$ -4.68M$ -7.83M$ -13.33M
EBITDA$ -2.39M$ -4.45M$ -1.97M$ -7.34M$ -12.88M
Net Income$ -2.89M$ -5.15M$ -3.39M$ -8.08M$ -13.75M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 1.16M$ 2.10M$ 3.39M$ 3.80M$ 11.47M
Total Debt$ 2.33M$ 1.92M$ 2.11M$ 1.90M$ 1.79M
Net Debt$ 2.24M$ 1.15M$ 1.91M$ 1.84M$ -4.85M
Total Liabilities$ 12.01M$ 10.25M$ 9.70M$ 7.49M$ 7.37M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -888.22K$ -2.46M-$ -6.66M$ -12.51M
Operating Cash Flow$ -1.39M$ -2.46M$ 112.11K$ -6.66M$ -12.51M
Investing Cash Flow
Financing Cash Flow
Currency in USD

IntelliPharmaCeutics International Earnings and Revenue History

IntelliPharmaCeutics International Debt to Assets

IntelliPharmaCeutics International Cash Flow

IntelliPharmaCeutics International Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.